← Back to Search

Decision Aid for Hypertensive Disorders of Pregnancy

N/A
Waitlist Available
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to speak and read English or Spanish
Be older than 18 years old
Must not have
Cardiovascular disease diagnosis (history of peripheral artery disease, stroke, or myocardial infarction)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one month after the initial assessment
Awards & highlights
No Placebo-Only Group

Summary

This trial studied how to help women reduce their risk of future heart disease after a complicated pregnancy.

Who is the study for?
This trial is for English or Spanish-speaking women who recently gave birth at the University of Utah and had high blood pressure issues during pregnancy. It's not open to those with a history of cardiovascular diseases like heart attack or stroke, or cognitive/vision impairments that would prevent understanding the study materials.
What is being tested?
The study is testing a decision aid designed to help these new mothers engage in preventive care against heart disease. Since they're at higher risk after having high blood pressure complications in pregnancy, this tool aims to guide them towards better heart health.
What are the potential side effects?
Since this trial involves using a decision aid rather than medication, there are no direct medical side effects. However, participants may experience stress or anxiety when considering their future health risks and making decisions about their care.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can speak and read English or Spanish.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of heart or blood vessel disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month after the initial assessment
This trial's timeline: 3 weeks for screening, Varies for treatment, and one month after the initial assessment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Decisional conflict

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Decision aidExperimental Treatment1 Intervention
Participants will use the decision aid in the postpartum period
Group II: Usual careActive Control1 Intervention
Participants will receive standard postpartum care

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,140 Previous Clinical Trials
1,697,700 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,934 Previous Clinical Trials
47,792,246 Total Patients Enrolled

Media Library

Decision aid Clinical Trial Eligibility Overview. Trial Name: NCT05826925 — N/A
Cardiovascular Disease Research Study Groups: Decision aid, Usual care
Cardiovascular Disease Clinical Trial 2023: Decision aid Highlights & Side Effects. Trial Name: NCT05826925 — N/A
Decision aid 2023 Treatment Timeline for Medical Study. Trial Name: NCT05826925 — N/A
~20 spots leftby Aug 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top